Mirabgeorn 50 mg/1
mirabegron · TABLET, FILM COATED, EXTENDED RELEASE · Qilu Pharmaceutical Co., Ltd.
No Recall History
Plain English
Mirabgeorn is a tablet, film coated, extended release containing mirabegron at 50 mg/1, taken oral. Manufactured by Qilu Pharmaceutical Co., Ltd..
Key Facts
- Brand Name
- Mirabgeorn
- Generic Name
- mirabegron
- NDC Code (Product)
67184-0572- Manufacturer
- Qilu Pharmaceutical Co., Ltd.
- Strength
- 50 mg/1
- Dosage Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA217989
- Drug Class
- beta3-Adrenergic Agonist [EPC]
- Marketing Start
- 06/30/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Mirabgeorn used for?
Mirabgeorn contains mirabegron. It is a tablet, film coated, extended release taken oral. Consult your doctor for specific uses.
Is Mirabgeorn a controlled substance?
Mirabgeorn is not classified as a controlled substance by the DEA.
What is the generic name for Mirabgeorn?
The generic name for Mirabgeorn is mirabegron. There are 11 other brand versions of mirabegron.
What is the NDC code for Mirabgeorn 50 mg/1?
The NDC (National Drug Code) for Mirabgeorn 50 mg/1 is 67184-0572, listed by Qilu Pharmaceutical Co., Ltd..